Prescribe RELEXXII With “DAW 1”
Specify DAW 1 on every prescription to help patients avoid pharmacy substitutions and receive RELEXXII as intended.
When their next dose seems out of reach, grab hold of RELEXXII
Personalized ADHD treatment with flexible dosing options
Careful dose optimization of methylphenidate has been shown to provide significant symptom management benefits.1
RELEXXII solves the ADHD medication dose gap with 45 mg and 63 mg strengths
Titration and management are made easier with multiple strengths in 9 mg increments.1,2 RELEXXII is the only branded methylphenidate to offer 45 mg and 63 mg strengths.
Don’t leave patients hanging during
ADHD medication dose adjustments
Available in seven strengths, RELEXXII provides one daily tablet for personalized ADHD treatment and symptom control.
PK & Bioequivalence
RELEXXII is designed with an immediate-release outer layer followed by controlled extended delivery of methylphenidate HCl throughout the day.2
Following the initial dose, methylphenidate concentrations gradually increase over several hours to support extended ADHD symptom control from morning through evening.2
Improve Classroom Attention & Behavior
In laboratory school studies, methylphenidate hydrochloride extended-release tablets demonstrated statistically significant improvement in ADHD symptoms, including attention and classroom behavior.2
Who’s right for RELEXXII?
For Patients Who Need an Individualized ADHD
Medication Dose
Explore patient scenarios and considerations that may help guide personalized ADHD treatment decisions.
Access and continuity for your patients
RELEXXII offers practical access resources to support prescription fulfillment, reduce ADHD medication
access disruptions, and improve affordability.
Help Patients Find RELEXXII
Medfinder helps patients locate nearby pharmacies that may have RELEXXII in stock or are able to order.
Patient Savings Resources
Eligible patient’s may pay as little as $0 per month* for their prescribed RELEXXII treatment.
References: 1. Childress AC, et al. Clin Pharmacol Drug Dev. 2025;0(0):1-7. 2. RELEXXII package insert. Vertical Pharmaceuticals, LLC.
All individuals depicted are models used for illustrative purposes only.
*Co-pay assistance is applicable to prescription coverage for eligible commercially insured patients. Offer void where prohibited. No income restrictions apply. Other restrictions may apply. Offer effective 04/2024. Alora Pharmaceuticals, LLC reserves the right to rescind, revoke, or amend this offer without notice. For full terms and conditions, click here.
ADHD=attention deficit hyperactivity disorder